Multifocal ERG before and after pars plana vitrectomy in ILM peeling: one year follow-up (2015)
- Authors:
- USP affiliated authors: MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP ; JORGE, RODRIGO - FMRP
- Unidade: FMRP
- Subjects: ELETRORRETINOGRAFIA; RETINA; ACUIDADE VISUAL
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Symposium of International Society for Clinical Electrophysiology of Vision (ISCEV)
-
ABNT
MESSIAS, André Márcio Vieira et al. Multifocal ERG before and after pars plana vitrectomy in ILM peeling: one year follow-up. 2015, Anais.. Ljubljana: ISCEV, 2015. . Acesso em: 29 dez. 2025. -
APA
Messias, A. M. V., Perches, A. C. D. L., Almeida, F., Messias, K. V., & Jorge, R. (2015). Multifocal ERG before and after pars plana vitrectomy in ILM peeling: one year follow-up. In Abstracts. Ljubljana: ISCEV. -
NLM
Messias AMV, Perches ACDL, Almeida F, Messias KV, Jorge R. Multifocal ERG before and after pars plana vitrectomy in ILM peeling: one year follow-up. Abstracts. 2015 ;[citado 2025 dez. 29 ] -
Vancouver
Messias AMV, Perches ACDL, Almeida F, Messias KV, Jorge R. Multifocal ERG before and after pars plana vitrectomy in ILM peeling: one year follow-up. Abstracts. 2015 ;[citado 2025 dez. 29 ] - Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema
- Intravitreal autologous bone marrow derived stem cells in ischemic macular edema: results after 6 months follow-up
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
